Incremental prognostic value of paradoxical blood pressure reduction after sympathetic stimulation in primary AL amyloidosis.

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Georgios Georgiopoulos

National & Kapodistrian University of Athens, Athens (Greece)

8 More presentations in this session

Presentation thumbnail

Discussant - Cardiac amyloidosis (3)

Presentation thumbnail

Evaluating diagnostic scoring systems for early detection of transthyretin amyloidosis in patients with HFpEF and left ventricular hypertrophy

Doctor D. Faro (Catania, IT)

Presentation thumbnail

Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.

Doctor M. Dicorato (Bari, IT)

Presentation thumbnail

Detection of arrhythmias in patients with transthyretin cardiac amyloidosis

Doctor I. Simkova (Olomouc, CZ)

Presentation thumbnail

Deep screening unveils hidden cardiac amyloidosis: carpal tunnel syndrome as a gateway to early transthyretin cardiac amyloidosis diagnosis

Doctor S. Yoshida (Kanazawa, JP)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Cardiac amyloidosis (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Sustained paradoxical vasodilation and blood pressure lowering in response to sympathetic stimulation as markers of disease severity and poor survival in primary AL amyloidosis.

Congress Presentation

Arterial-myocardial coupling in primary AL amyloidosis. A validation study of vascular involvement.

Congress Presentation

Cardiac remodelling and sympathetic activation in cardiac amyloidosis: insights from transcardiac blood sampling

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources